(Q36965872)

English

Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome

scientific article published on July 2013

Statements

Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome (English)
D Colas
B Chuluun
D Warrier
M Blank
D Z Wetmore
P Buckmaster
C C Garner
H C Heller
1 July 2013
169
963-973

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit